Form 144 Cellebrite DI Ltd. Filed by: GEE DAVID NICHOLAS
Cellebrite DI Ltd. - Ordinary Shares (CLBT)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
CLBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLBT alerts
High impacting Cellebrite DI Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLBT
News
- Cellebrite DI Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Craig Hallum from $23.00 to $24.00. They now have a "buy" rating on the stock.MarketBeat
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $21.00 to $22.00. They now have an "overweight" rating on the stock.MarketBeat
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $17.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- Cellebrite DI Ltd (CLBT) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]Yahoo! Finance
CLBT
Earnings
- 11/6/24 - Beat
CLBT
Sec Filings
- 11/14/24 - Form 144
- 11/14/24 - Form 144
- 11/14/24 - Form 144
- CLBT's page on the SEC website